The thinking behind
the doing.

Traditional pharmaceutical manufacturing demands massive upfront capital and infrastructure. But what if we could build a global pharma company without owning a single factory? This is the story of how HRV Pharma is pioneering India's first integrated virtual API company, proving that smart partnerships and compliance-first thinking can unlock markets traditional models can't reach.

Playing badminton at an international level - competing across countries, adapting to different playing styles, and performing under pressure - taught me more about business strategy than most MBA courses. Every match required preparation, pattern recognition, and mid-game adaptation. These same principles guide how I build companies and make decisions under uncertainty.

Despite advances in drug discovery and manufacturing, emerging markets continue to face significant barriers to pharmaceutical access. The problem isn't just about cost - it's about regulatory complexity, distribution inefficiencies, and business models optimized for large, established markets. Here's how we're working to change that equation.

I focus on building businesses that create sustainable value by prioritizing long-term partnerships, compliance, and resilient systems over rapid scaling and quick exits. This philosophy ensures the pharmaceutical supply chain remains stable and trustworthy for decades, which is critical when dealing with essential, life-saving APIs and drugs.